8123190|t|Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.
8123190|a|Serotonergic (5-HT) and dopaminergic activities have been examined in Lewy Body Dementia (LBD) and compared with Parkinson's disease (PD) and Alzheimer's disease (AD). In the neocortex the LBD subgroup experiencing hallucinations was distinguished from the other categories by an increase in the 5HIAA:5HT ratio measured in frontal cortex and by the serotonergic (5-HIAA or 5-HIAA:5-HT): cholinergic (choline acetyltransferase) ratio in frontal and temporal cortex. In the neostriatum (caudate nucleus), loss of dopamine and increased HVA:dopamine ratio correlated with the reduction in substantia nigra neurons in LBD but not PD, despite the greater loss of neurones and dopamine and the higher dopamine turnover ratio in PD. LBD patients experiencing severe Parkinsonism as a result of neuroleptic treatment tended to have lower neuron counts, in combination with higher turnover ratios, than the remainder. Qualitative differences between LBD and PD included decreased cortical 5-HT turnover in PD compared with the increase in LBD. There were no significant changes in any parameter in AD, with the exception of a reduction in temporal cortex 5HIAA. The results suggest that although the neurochemical pathology of LBD and PD involves similar systems, the nature of the derangements differs sufficiently between the diseases to account for differences in symptomatology.
8123190	28	46	Lewy body dementia	Disease	MESH:D020961
8123190	60	72	hallucinosis	Disease	MESH:D001523
8123190	102	114	Serotonergic	Chemical	-
8123190	116	120	5-HT	Chemical	MESH:D012701
8123190	126	138	dopaminergic	Chemical	MESH:D004298
8123190	172	190	Lewy Body Dementia	Disease	MESH:D020961
8123190	192	195	LBD	Disease	MESH:D020961
8123190	215	234	Parkinson's disease	Disease	MESH:D010300
8123190	236	238	PD	Disease	MESH:D010300
8123190	244	263	Alzheimer's disease	Disease	MESH:D000544
8123190	265	267	AD	Disease	MESH:D000544
8123190	291	294	LBD	Disease	MESH:D020961
8123190	317	331	hallucinations	Disease	MESH:D006212
8123190	398	407	5HIAA:5HT	Chemical	-
8123190	452	464	serotonergic	Chemical	-
8123190	466	472	5-HIAA	Chemical	MESH:D006897
8123190	476	487	5-HIAA:5-HT	Chemical	-
8123190	614	622	dopamine	Chemical	MESH:D004298
8123190	637	640	HVA	Chemical	MESH:D006719
8123190	641	649	dopamine	Chemical	MESH:D004298
8123190	717	720	LBD	Disease	MESH:D020961
8123190	729	731	PD	Disease	MESH:D010300
8123190	774	782	dopamine	Chemical	MESH:D004298
8123190	798	806	dopamine	Chemical	MESH:D004298
8123190	825	827	PD	Disease	MESH:D010300
8123190	829	832	LBD	Disease	MESH:D020961
8123190	833	841	patients	Species	9606
8123190	862	874	Parkinsonism	Disease	MESH:D010302
8123190	1044	1047	LBD	Disease	MESH:D020961
8123190	1052	1054	PD	Disease	MESH:D010300
8123190	1083	1087	5-HT	Chemical	MESH:D012701
8123190	1100	1102	PD	Disease	MESH:D010300
8123190	1133	1136	LBD	Disease	MESH:D020961
8123190	1192	1194	AD	Disease	MESH:D000544
8123190	1321	1324	LBD	Disease	MESH:D020961
8123190	1329	1331	PD	Disease	MESH:D010300
8123190	Positive_Correlation	MESH:D004298	MESH:D006719
8123190	Negative_Correlation	MESH:D012701	MESH:D010300
8123190	Negative_Correlation	MESH:D004298	MESH:D020961
8123190	Association	MESH:D006719	MESH:D020961
8123190	Positive_Correlation	MESH:D012701	MESH:D020961

